Dion Madsen joined BDC Capital in 2012 as Senior Managing Partner in the Healthcare Venture Fund.
Dion brings over 15 years of senior management experience as a financial executive and venture investor, most recently as Founder and Managing Director of Physic Ventures, and as Managing Director of Unilever Technology Ventures, Unilever’s North American corporate venture fund. Prior to Unilever, Dion led Chiron Corporation’s investor communications, as Director of Investor Relations, and buit a new strategy for the company’s $500M BioPharma business. Before moving to San Francisco, Dion spent five years as Partner of RBC Capital Partners’ Life Sciences Venture Fund, the first third-party capital fund in RBC Capital Partners’ history.
Dion is a founding member of C100, a select group of the top 100 Canadians in the San Francisco Bay area, and has sat on the boards of directors of many venture capital funds and companies in the pharmaceutical and health care industries. He has also held the roles of M&A Advisor, Strategic Consultant and CFO for a biotechnology company.
He currently sits on the Board of Directors of Interface Biologics and Xagenic and is a Board observer at Agrisoma Biosciences, Phemi Health Systems and Chromatin. He is also a selection committee member of the San Francisco Canadian Technology Accelerator.
Dion is a CFA® charterholder and has a Bachelor of Commerce in Finance and Marketing from the University of Saskatchewan.